The WACC of Sigilon Therapeutics, Inc. (SGTX) is 7.4%.
| Range | Selected | |
| Cost of equity | 6.70% - 9.10% | 7.90% |
| Tax rate | 26.20% - 27.00% | 26.60% |
| Cost of debt | 7.00% - 9.00% | 8.00% |
| WACC | 6.3% - 8.5% | 7.4% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.62 | 0.76 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 6.70% | 9.10% |
| Tax rate | 26.20% | 27.00% |
| Debt/Equity ratio | 0.33 | 0.33 |
| Cost of debt | 7.00% | 9.00% |
| After-tax WACC | 6.3% | 8.5% |
| Selected WACC | 7.4% | |